Research output: Contribution to journal › Article › peer-review
RhII-Catalyzed De-symmetrization of Ethane-1,2-dithiol and Propane-1,3-dithiol Yields Metallo-β-lactamase Inhibitors. / Krasavin, Mikhail; Zhukovsky, Daniil; Solovyev, Igor; Barkhatova, Darina; Dar'in, Dmitry; Frank, Denia; Martinelli, Giada; Weizel, Lilia; Proschak, Anna; Rotter, Marco; Kramer, Jan S.; Brunst, Steffen; Wichelhaus, Thomas A.; Proschak, Ewgenij.
In: ChemMedChem, Vol. 16, No. 22, 19.11.2021, p. 3410-3417.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - RhII-Catalyzed De-symmetrization of Ethane-1,2-dithiol and Propane-1,3-dithiol Yields Metallo-β-lactamase Inhibitors
AU - Krasavin, Mikhail
AU - Zhukovsky, Daniil
AU - Solovyev, Igor
AU - Barkhatova, Darina
AU - Dar'in, Dmitry
AU - Frank, Denia
AU - Martinelli, Giada
AU - Weizel, Lilia
AU - Proschak, Anna
AU - Rotter, Marco
AU - Kramer, Jan S.
AU - Brunst, Steffen
AU - Wichelhaus, Thomas A.
AU - Proschak, Ewgenij
N1 - Publisher Copyright: © 2021 The Authors. ChemMedChem published by Wiley-VCH GmbH.
PY - 2021/11/19
Y1 - 2021/11/19
N2 - Diversity-oriented synthesis (DOS) is a rich source for novel lead structures in Medicinal Chemistry. In this study, we present a DOS-compatible method for synthesis of compounds bearing a free thiol moiety. The procedure relies on Rh(II)-catalyzed coupling of dithiols to diazo building blocks. The synthetized library was probed against metallo-β-lactamases (MBLs) NDM-1 and VIM-1. Biochemical and biological evaluation led to identification of novel potent MBL inhibitors with antibiotic adjuvant activity.
AB - Diversity-oriented synthesis (DOS) is a rich source for novel lead structures in Medicinal Chemistry. In this study, we present a DOS-compatible method for synthesis of compounds bearing a free thiol moiety. The procedure relies on Rh(II)-catalyzed coupling of dithiols to diazo building blocks. The synthetized library was probed against metallo-β-lactamases (MBLs) NDM-1 and VIM-1. Biochemical and biological evaluation led to identification of novel potent MBL inhibitors with antibiotic adjuvant activity.
KW - diazo compounds
KW - metallo β lactamases
KW - multiresistant bacteria
KW - Rh(II) catalysis
KW - thiol inhibitors
KW - DIAZO
KW - KETONES
KW - metallo beta lactamases
UR - http://www.scopus.com/inward/record.url?scp=85112073080&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/5993ce08-8619-3834-bbbe-d8bbbc29f6a8/
U2 - 10.1002/cmdc.202100344
DO - 10.1002/cmdc.202100344
M3 - Article
C2 - 34184833
AN - SCOPUS:85112073080
VL - 16
SP - 3410
EP - 3417
JO - Farmaco
JF - Farmaco
SN - 1860-7179
IS - 22
ER -
ID: 84793973